GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Debt-to-Revenue

Voluntis (XPAR:ALVTX) Debt-to-Revenue : 3.31 (As of Jun. 2021)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Voluntis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was €4.38 Mil. Voluntis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was €4.36 Mil. Voluntis's annualized Revenue for the quarter that ended in Jun. 2021 was €2.64 Mil. Voluntis's annualized Debt-to-Revenue for the quarter that ended in Jun. 2021 was 3.31.


Voluntis Debt-to-Revenue Historical Data

The historical data trend for Voluntis's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Debt-to-Revenue Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Debt-to-Revenue
0.68 0.58 0.70 2.09 1.85

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.20 2.36 1.58 1.66 3.31

Competitive Comparison of Voluntis's Debt-to-Revenue

For the Health Information Services subindustry, Voluntis's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Voluntis's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Voluntis's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Voluntis's Debt-to-Revenue falls into.



Voluntis Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Voluntis's Debt-to-Revenue for the fiscal year that ended in Dec. 2020 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.088 + 6.062) / 4.398
=1.85

Voluntis's annualized Debt-to-Revenue for the quarter that ended in Jun. 2021 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(4.381 + 4.359) / 2.644
=3.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2021) Revenue data.


Voluntis Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Voluntis's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines